CLASS II ONGOING Device recall · Reported 27 Jan 2021 · FDA Enforcement Report

REF 27219-2 X1, Medtronic, Delta Valve, Neonatal, Performance Level recalled

Medtronic Neurosurgery is recalling REF 27219-2 X1, Medtronic, Delta Valve, Neonatal, Performance Level, distributed nationwide in the US. The recall was initiated on 16 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 0219281777
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0872-2021
FDA event ID
87069
Recalling firm
Medtronic Neurosurgery, Irvine, CA
Classification
Class II
Status
Ongoing
Recall initiated
16 Dec 2020
FDA classified
15 Jan 2021
Reported
27 Jan 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

16 Dec 2020Recall initiated by company
15 Jan 2021Classified by FDA+30 days
27 Jan 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Neonatal Valves were manufactured with a ventricular catheter connection site shorter than the design specification. The defect can lead to difficulty in securing the valve to the proximal catheter which could result in disconnection of the ventricular catheter from the valve and shunt malfunction

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

REF 27219-2 X1, Medtronic, Delta Valve, Neonatal, Performance Level 2.0, CE 0344, Sterile EO - Product Usage: Neonatal Delta Snap Shunt Assemblies are components of CSF-Flow Control Shunt Systems designed to provide controlled CSF flow from the ventricles of the brain into the peritoneal cavity.

Where it was distributed

Worldwide distribution - US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, IL, KS, KY, LA, MA, MI, MO, NV, NM, NY, ND, OH, OK, TN, VA and the countries of Albania, Australia, Brazil, Cyprus, Ireland, Mexico, Qatar, Romania, Russian Federation, Serbia, South Africa, Spain, United Kingdom.

Nationwide AlabamaArizonaCaliforniaColoradoFloridaGeorgiaIllinoisKansasKentuckyLouisianaMassachusettsMichiganMissouriNorth DakotaNew MexicoNevadaNew YorkOhioOklahomaTennessee

Questions about this recall

Why was it recalled?

Neonatal Valves were manufactured with a ventricular catheter connection site shorter than the design specification. The defect can lead to difficulty in securing the valve to the proximal catheter which could result in disconnection of the ventricular catheter from the valve and shunt malfunction

Which lots are affected?

Lot # 0219281777

Where was it sold?

Worldwide distribution - US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, IL, KS, KY, LA, MA, MI, MO, NV, NM, NY, ND, OH, OK, TN, VA and the countries of Albania, Australia, Brazil, Cyprus, Ireland, Mexico, Qatar, Romania, Russian Federation, Serbia, South Africa, Spain, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 87069

More recalls from Medtronic Neurosurgery

All 32

Other Other Medical Devices recalls

All 13,857